Updates in Treatment Strategies for Advanced Biliary Tract Cancer
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss advances in treatment options in advanced biliary tract cancer.
EP. 1: Prognosis and Standards of Care in Advanced Biliary Tract Cancer
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD, and Rachna Shroff, MD, MS, FASCO, and a patient discuss prognosis and standard-of-care treatment for patients with advanced biliary tract cancer.
EP. 2: Discussion of a Patient Case of Advanced BTC
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD, and Rachna Shroff, MD, MS, FASCO, discuss a case of advanced biliary tract cancer with a patient.
EP. 3: Homing in on the TOPAZ-1 Trial in Biliary Tract Cancer
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss the phase 3 TOPAZ-1 trial in advanced biliary tract cancer.
EP. 4: Putting TOPAZ-1 Data into Context for Patients With Advanced BTC
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient put the TOPAZ-1 data into context for patients with advanced biliary tract cancer.
EP. 5: Clinical Implications of 3-Year OS Data With Durvalumab/Chemo in Advanced BTC
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss the clinical implications of 3-year survival data from TOPAZ-1 in advanced biliary tract cancer.
EP. 6: Considering Factors When Choosing Among IO Agents in Advanced BTC
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss considering factors for immunotherapy agents in advanced biliary tract cancer.
EP. 7: Factoring in Trastuzumab Deruxtecan in the Advanced BTC Setting
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss how to factor in trastuzumab deruxtecan in advanced biliary tract cancer.
EP. 8: The Investigational Pipeline for Advanced BTC
Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss ongoing research efforts in advanced biliary tract cancer.
